Table 2 Clinical features of patients with FCD IIb in the present cohort
From: Identification and immunophenotype of abnormal cells present in focal cortical dysplasia type IIb
Case number | Sex | Age at surgery (year) | Age of epilepsy onset (year) | Approximate seizure frequency (per month) | Duration of epilepsy (years) | Epileptogenic region |
|---|---|---|---|---|---|---|
1 | M | 6 | < 1 | 400 | 6 | R-Fr |
2 | F | 19 | 1 | 180 | 18 | R-T |
3 | F | 34 | 3 | 30 | 31 | R-T |
4 | F | 41 | 3 | 30 | 38 | R-Fr |
5 | M | 5 | < 1 | 150 | 5 | R-TPO |
6 | F | 2 | < 1 | 150 | 2 | R-T |
7 | F | 5 | < 1 | 150 | 5 | R-TO |
8 | F | < 1 | < 1 | 150 | 0.75 | L-Fr |
9 | M | 3 | 1 | 150 | 2 | L-Fr |
10 | F | 16 | 8 | 90 | 8 | Fr |
11 | M | 22 | 4 | 30 | 18 | L-Fr |
12 | F | 21 | 4 | 30 | 17 | Fr |
13 | F | 12 | < 1 | 4 | 12.5 | R-O |
14 | F | 9 | 6 | 120 | 9 | L-Fr |
15 | M | 20 | 7 | 30 | 13 | Fr |
16 | M | 35 | 2 | 30 | 33 | L-Fr |
17 | M | 40 | 19 | 4 | 21 | R-T |
18 | M | 36 | 19 | 30 | 17 | L-Fr |